Coherus Biosciences (CHRS) Revenue (2013 - 2026)
Coherus Biosciences (CHRS) revenue from Sep 30, 2013 to Mar 31, 2026. The TTM Coherus Biosciences (CHRS) revenue is $47M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Coherus Biosciences (CHRS) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +47.98% |
| 3 Years TTM | -36.53% |
| 5 Years TTM | -36.18% |
| 10 Years TTM | +2.51% |
Annual Revenue change of Coherus Biosciences (CHRS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $12M | -70.81% |
| 2025 | $42M | +59.80% |
| 2024 | $26M | -89.74% |
| 2023 | $257M | +21.89% |
| 2022 | $211M | -35.37% |
| 2021 | $327M | -31.37% |
| 2020 | $476M | +284.16% |
| 2019 | $124M | N/A |
| 2018 | $0 | -100.00% |
| 2017 | $1.56M | -99.18% |
| 2016 | $189M | +530.76% |
| 2015 | $30M | -3.44% |
| 2014 | $31M | +1031.27% |
| 2013 | $2.75M | +44.74% |
| 2012 | $1.90M | N/A |
Comparison Coherus Biosciences (CHRS) five years revenue CAGR with competitors
Coherus Biosciences (CHRS) five years revenue CAGR is -36.18%.